Acquisition Announced

Eli Lilly and Company acquisition of Orna Therapeutics

US$2.4bn consideration

Announced 9 Feb 2026

Advisers

Target
Orna Therapeutics
Acquirer
Eli Lilly and Company
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Pharma

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.